EUROPEAN COMMISSION

We aimed to prioritise the most relevant indicators that support the key aims of EU funded biomedical and health R&I; and feasible indicators based on availability of good quality, publicly available datasets that would be relevant for different stages in the pathways and relating to the different indicators.